Trial Profile
Investigation of a preseasonal rush treatment scheme with Depigoid Grass Mix as an add-on therapy in patients with allergic rhinitis and/or rhinoconjunctivitis sensitized to grass pollen
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 14 Feb 2012
Price :
$35
*
At a glance
- Drugs Grass pollen allergy immunotherapy (Primary)
- Indications Allergic asthma; Allergic rhinoconjunctivitis; Grass pollen hypersensitivity; Seasonal allergic rhinitis
- Focus Therapeutic Use
- 29 Jun 2011 New trial record